NeurogesX

Study of NGX-1998 for the Treatment of Postherpetic Neuralgia

Role: lead

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

Role: lead

Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)

Role: lead

A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers

Role: lead

Effect of NGX-4010 on ENFD and Sensory Function

Role: lead

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Role: lead

Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function

Role: lead

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Role: lead

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Role: lead

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Role: lead

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

Role: lead

NGX-4010 for the Treatment of Postherpetic Neuralgia

Role: lead

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

Role: lead

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

Role: lead

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

Role: lead

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Role: lead

An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

Role: lead